TAFINLAR + MEKINIST. for more moments FOR PATIENTS WITH A CERTAIN TYPE OF BRAF+ ADVANCED MELANOMA

Size: px
Start display at page:

Download "TAFINLAR + MEKINIST. for more moments FOR PATIENTS WITH A CERTAIN TYPE OF BRAF+ ADVANCED MELANOMA"

Transcription

1 Treatment guide for patients and caregivers FOR PATIENTS WITH A CERTAIN TYPE OF BRAF+ ADVANCED MELANOMA TAFINLAR + MEKINIST A treatment option specifically made for your type of melanoma for more moments INDICATION TAFINLAR (dabrafenib) and MEKINIST (trametinib) are prescription medicines that can be used in combination to treat people with a type of skin cancer called melanoma: That has spread to other parts of the body (metastatic) or cannot be removed by surgery (unresectable), and That has a certain type of abnormal BRAF (V600E or V600K mutation-positive) gene. TAFINLAR, in combination with MEKINIST, is not used to treat people with a type of skin cancer called wild-type BRAF melanoma. MEKINIST should not be used to treat people who already have received a BRAF inhibitor for treatment of their melanoma. Your health care provider will perform a test to make sure that TAFINLAR and MEKINIST, in combination, are right for you. It is not known if TAFINLAR and MEKINIST, in combination, are safe and effective in children.

2 Table of Contents Y ou are probably experiencing many emotions as you process all the information provided by your doctor. The good news is that you have a treatment option that s made for your type of cancer, plus the support of your family, friends, and health care team. This guide is meant to help you and those close to you understand your treatment with TAFINLAR (dabrafenib) + MEKINIST (trametinib) combination therapy. Understanding your type of advanced melanoma What is a BRAF mutation? A treatment option that s made for your type of cancer Potential benefits of TAFINLAR + MEKINIST therapy Summary of Important Information Getting started on TAFINLAR + MEKINIST Storing TAFINLAR and MEKINIST Getting the most out of your treatment Questions to ask your doctor Tips your doctor may suggest for coping with fever Tips your doctor may suggest for managing other common side effects Frequently asked questions How can I learn more about melanoma? Resources and support

3 4 5 Understanding your type of advanced melanoma Understanding your type of advanced melanoma (unresectable or metastatic) is the first part of your treatment journey. It will help you to understand why your doctor has prescribed TAFINLAR (dabrafenib) + MEKINIST (trametinib) for you, and will help you in conversations with your health care team. What is a BRAF mutation? Sometimes changes occur within the DNA of your cells. The type of advanced melanoma you have can be based on the presence or absence of genetic changes within the melanoma cells. These genetic changes are referred to as mutations. Melanoma is a type of skin cancer that begins in the cells which give skin its color (melanocytes). Two common types of mutations found in advanced melanoma are BRAF V600E and V600K. It means that the BRAF gene within the cell is damaged, and sends the wrong signals, causing cells to grow and spread out of control. Metastatic means that your cancer (in this case, melanoma) has spread to other parts of your body either through your bloodstream or your lymph nodes. An inoperable tumor is sometimes referred to as unresectable. Both terms mean that the tumor or tumors can t be completely removed by surgery, either because they have spread to too many places or their location makes the surgery very challenging. Doctors will determine the stage of your melanoma, according to the extent of cancer in your body, by using physical examinations and specific imaging tests. With advanced melanoma, a biopsy (or tissue sample) of the cells will be tested to see if it contains a BRAF mutation, other gene mutation, or no known mutation. When doctors know for sure that the advanced melanoma has a damaged BRAF gene, they call it BRAF-positive advanced melanoma. You may see this written as BRAF+ advanced melanoma. BRAF As many as 50% of patients with advanced melanoma have one of these gene mutations. Knowing your BRAF mutation status can be crucial when choosing an appropriate treatment. IMPORTANT SAFETY INFORMATION TAFINLAR and MEKINIST may cause serious side effects, including the risk of new cancers: TAFINLAR, when used in combination with MEKINIST, may cause a type of skin cancer called cutaneous squamous cell carcinoma (cuscc). New melanoma lesions have also occurred. TAFINLAR and MEKINIST in combination may cause new cancers, including basal cell carcinoma. Talk with your health care provider about your risk for these cancers. Check your skin and tell your health care provider right away about any skin changes, including a new wart, skin sore, or reddish bump that bleeds or does not heal, or a change in size or color of a mole. and the Summary of Important Information on pages Your health care provider should check your skin before you start treatment, and every 2 months while on treatment, to look for any new skin cancers. Your health care provider should continue to check your skin for 6 months after you stop taking TAFINLAR and MEKINIST. Your health care provider should also check for cancers that may not occur on the skin. Tell your health care provider about any new symptoms that have developed while taking TAFINLAR and MEKINIST in combination.

4 6 7 A treatment option that s made for your type of cancer Patients with BRAF mutations have the option of taking targeted therapies, such as BRAF and MEK inhibitors, which are designed to target cells with the BRAF gene mutation and treat this form of advanced melanoma. These targeted therapies are intended to work by blocking the action of certain proteins associated with the BRAF gene so that they inhibit the faulty signals that can lead to the growing and spreading of cancer cells such as melanoma. Targeted therapy can also affect healthy cells. TAFINLAR (dabrafenib) + MEKINIST (trametinib) combination therapy targets 2 different points in a pathway that sends signals in cells. Although TAFINLAR + MEKINIST combination therapy has been studied in patients who have advanced melanoma with a mutated BRAF gene, the way that TAFINLAR + MEKINIST combination therapy works has only been shown in laboratory studies. Medical research has shown that TAFINLAR + MEKINIST combination therapy may slow the growth of certain melanoma cancer cells that have an abnormal BRAF gene. TAFINLAR + MEKINIST combination therapy can be used to treat people with a type of advanced melanoma: that has spread to other parts of the body (for example, the liver, lungs, and brain) or cannot be removed by surgery, and that has a certain type of abnormal BRAF (V600E or V600K mutation positive) gene as determined by an FDA-approved test TAFINLAR and MEKINIST in combination may cause serious side effects, including: Bleeding problems. TAFINLAR and MEKINIST in combination can cause serious bleeding problems, especially in your brain or stomach, and can lead to death. Call your health care provider and get medical help right away if you have any signs of bleeding, including: headaches, dizziness, or feeling weak coughing up blood or blood clots vomiting blood or your vomit looks like coffee grounds red or black stools that look like tar 7

5 8 Potential benefits of TAFINLAR + MEKINIST therapy TAFINLAR (dabrafenib) + MEKINIST (trametinib) may offer a chance to extend your life* More patients had their tumors shrink or disappear (known as the "overall response rate") with TAFINLAR + MEKINIST 9 Patients taking TAFINLAR + MEKINIST lived significantly longer than patients taking TAFINLAR Patients lived longer without their disease worsening with TAFINLAR + MEKINIST TAFINLAR + MEKINIST Overall response rate Half of patients taking each treatment were alive after: Half of patients taking each treatment were alive without their disease worsening after: 66% TAFINLAR TAFINLAR + + MEKINIST MEKINIST VS MONTHS MONTHS TAFINLAR TAFINLAR VS MONTHS MONTHS TAFINLAR TAFINLAR + + MEKINIST MEKINIST MONTHS MONTHS VS TAFINLAR TAFINLAR VS MONTHS MONTHS TAFINLAR Overall response rate 51% * As demonstrated by a clinical trial that included 423 adult patients with BRAF V600E/K mutation positive unresectable or metastatic melanoma that was previously untreated. Patients were treated with a combination of TAFINLAR + MEKINIST or TAFINLAR alone. Inflammation of the colon and bleeding in the stomach or intestines. MEKINIST, alone or in combination with TAFINLAR, can cause inflammation of the colon and bleeding in the stomach or intestines that can lead to death. Tell your health care provider immediately if you have any of the following symptoms: diarrhea stomach or abdominal pain fever nausea Blood clots. TAFINLAR and MEKINIST in combination can cause blood clots in your arms or legs, which can travel to your lungs and lead to death. Get medical help right away if you have the following symptoms: chest pain sudden shortness of breath or trouble breathing pain in your legs with or without swelling swelling in your arms or legs a cool pale arm or leg Heart problems, including heart failure. Your health care provider should check your heart function before you start taking TAFINLAR and MEKINIST in combination, and during treatment. Call your health care provider right away if you have any of the following signs and symptoms of a heart problem: feeling like your heart is pounding or racing shortness of breath swelling of your ankles and feet feeling lightheaded Tumors disappeared completely in 10% of patients taking TAFINLAR + MEKINIST and 8% of patients taking TAFINLAR Tumors shrank in 56% of patients taking TAFINLAR + MEKINIST and 42% of patients taking TAFINLAR Tumors shrank or disappeared for an average of 9.2 months with TAFINLAR + MEKINIST and 10.2 months with TAFINLAR Eye problems. TAFINLAR and MEKINIST, in combination, can cause severe eye problems that can lead to blindness. Call your health care provider right away if you get these symptoms of eye problems: blurred vision, loss of vision, or other vision changes seeing color dots halo (seeing blurred outline around objects) eye pain, swelling, or redness Lung or breathing problems. TAFINLAR and MEKINIST, in combination, can cause lung or breathing problems. Tell your health care provider if you have any new or worsening symptoms of lung or breathing problems, including: shortness of breath cough

6 10 11 Summary of IMPORTANT INFORMATION What are TAFINLAR (dabrafenib) and MEKINIST (trametinib)? TAFINLAR and MEKINIST are prescription medicines used in combination to treat people with a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery, and that has a certain type of abnormal BRAF gene. Your health care provider will perform a test to make sure that TAFINLAR and MEKINIST are right for you. TAFINLAR and MEKINIST are not used to treat people with a type of skin cancer called wild-type BRAF melanoma. MEKINIST should not be used to treat people who already have received a BRAF inhibitor for treatment of their melanoma. It is not known if TAFINLAR and MEKINIST are safe and effective in children. What is the most important information I should know about TAFINLAR and MEKINIST? TAFINLAR and MEKINIST may cause serious side effects, including the risk of new cancers such as a type of skin cancer called cutaneous squamous cell carcinoma, basal cell carcinoma, or new melanoma lesions. Talk to your health care provider about your risk for these cancers. Check your skin and tell your health care provider right away about any skin changes including a new wart, skin sore, or reddish bump that bleeds or does not heal, or a mole that changes size or color. Your health care provider should check your skin before treatment with TAFINLAR and MEKINIST, every 2 months during treatment and for up to 6 months after you stop taking TAFINLAR and MEKINIST to look for any new skin cancers. Your health care provider should also check for cancers that may not occur on the skin. Tell your health care provider about any new symptoms that develop during treatment with TAFINLAR and MEKINIST. What warnings should I know about TAFINLAR and MEKINIST? TAFINLAR and MEKINIST may cause serious side effects, including: Bleeding problems. TAFINLAR and MEKINIST in combination can cause serious bleeding problems, especially in your brain or stomach, and can lead to death. Call your health care provider and get medical help right away if you have any signs of bleeding, including: headaches, dizziness, or feeling weak coughing up blood or blood clots vomiting blood or your vomit looks like coffee grounds red or black stools that look like tar Blood clots. TAFINLAR and MEKINIST in combination can cause blood clots in your arms or legs, which can travel to your lungs and lead to death. Get medical help right away if you have the following symptoms: chest pain sudden shortness of breath or trouble breathing pain in your legs with or without swelling swelling in your arms or legs a cool pale arm or leg Heart problems, including heart failure. Your health care provider should check your heart function before you start taking TAFINLAR and MEKINIST in combination, and during treatment. Call your health care provider right away if you have any of the following signs and symptoms of a heart problem: feeling like your heart is pounding or racing shortness of breath swelling of your ankles and feet feeling lightheaded Eye problems. TAFINLAR and MEKINIST, in combination, can cause severe eye problems that can lead to blindness. Call your health care provider right away if you get these symptoms of eye problems: blurred vision, loss of vision, or other vision changes seeing color dots halo (seeing blurred outline around objects) eye pain, swelling, or redness Lung or breathing problems. TAFINLAR and MEKINIST, in combination, can cause lung or breathing problems. Tell your health care provider if you have any new or worsening symptoms of lung or breathing problems such as shortness of breath or cough. Fever. Fever is common during treatment with TAFINLAR and MEKINIST, but it may also be serious. When taking TAFINLAR and MEKINIST, in combination, fever may happen often or may be severe. In some cases, chills or shaking chills, too much fluid loss (dehydration), low blood pressure, dizziness, or kidney problems may happen with the fever. Call your health care provider right away if you get a fever while taking TAFINLAR or MEKINIST. Skin reactions. Rash is a common side effect of TAFINLAR and MEKINIST in combination. In some cases these rashes and other skin reactions can be severe, and may need to be treated in a hospital. Call your health care provider if you get any of the following symptoms: skin rash that bothers you or does not go away acne redness, swelling, peeling, or tenderness of hands or feet skin redness Inflammation of the colon and bleeding in the stomach or intestines. MEKINIST, alone or in combination with TAFINLAR, can cause inflammation of the colon and bleeding in the stomach or intestines that can lead to death. Tell your health care provider immediately if you have any of the following symptoms: diarrhea stomach or abdominal pain fever nausea

7 12 13 Summary of IMPORTANT INFORMATION (continued) Increased blood sugar (hyperglycemia). Some people may develop high blood sugar or worsening diabetes during treatment with TAFINLAR (dabrafenib) and MEKINIST (trametinib) in combination. If you are diabetic, your health care provider should check your blood sugar levels closely during treatment with TAFINLAR and MEKINIST. Your diabetes medicine may need to be changed. Tell your health care provider if you have symptoms of severe high blood sugar such as increased thirst, urinating more often than normal, or producing an increased amount of urine. Glucose-6-phosphate dehydrogenase (G6PD) deficiency. TAFINLAR may cause healthy red blood cells to break down too early in people with G6PD deficiency. This may lead to a type of anemia called hemolytic anemia, where the body does not have enough healthy red blood cells. Tell your health care provider if you have any of the following signs or symptoms: yellow skin (jaundice), weakness or dizziness, or shortness of breath. What should I tell my health care provider before taking TAFINLAR and MEKINIST? Before you take TAFINLAR and MEKINIST, tell your health care provider if you: Have had bleeding problems or blood clots Have inflammation of the colon Have heart problems Have eye problems Have lung or breathing problems Have high blood pressure (hypertension) Have liver or kidney problems Have diabetes Have a deficiency of the glucose-6-phosphate dehydrogenase (G6PD) enzyme Have any other medical conditions Plan to have surgery, dental, or other medical procedures Are pregnant or plan to become pregnant TAFINLAR and MEKINIST, in combination, may harm your unborn baby. Females who are able to become pregnant should use birth control (contraception) during treatment with TAFINLAR and MEKINIST, in combination, and for 4 months after stopping treatment with TAFINLAR and MEKINIST. Birth control using hormones (such as birth control pills, injections, or patches) may not work as well while you are taking TAFINLAR and MEKINIST in combination. You should use another effective method of birth control while taking TAFINLAR and MEKINIST in combination. Talk to your health care provider about birth control methods that may be right for you during this time. TAFINLAR and MEKINIST in combination may cause fertility problems in females. This could affect your ability to become pregnant. TAFINLAR may cause lower sperm counts in males. This could affect the ability to father a child. Talk to your health care provider if this is a concern for you. Are breastfeeding or planning to breastfeed It is not known if TAFINLAR or MEKINIST passes into your breast milk. Do not breastfeed during treatment and for 4 months after your last dose of TAFINLAR and MEKINIST. Talk to your health care provider about the best way to feed your baby during this time. Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking TAFINLAR and MEKINIST with certain other medicines can affect each other, causing side effects. TAFINLAR and MEKINIST may affect the way other medicines work, and other medicines can affect how TAFINLAR and MEKINIST work. You can ask your pharmacist for a list of medicines that may interact with TAFINLAR and MEKINIST. Know the medicines you take. Keep a list of them to show your health care provider and pharmacist when you get a new medicine. What are other side effects of TAFINLAR and MEKINIST in combination? Other common side effects of TAFINLAR and MEKINIST in combination include: Nausea Chills Diarrhea Vomiting High blood pressure (hypertension) Your health care provider should check your blood pressure during treatment. Call your health care provider right away if you develop high blood pressure, your blood pressure worsens, or you have a severe headache, lightheadedness, or dizziness Swelling of the face, arms, or legs Headache Joint aches Cough General Information about the Safe and Effective Use of TAFINLAR and MEKINIST Do not use TAFINLAR and MEKINIST for a condition for which it was not prescribed. Do not give TAFINLAR and MEKINIST to other people, even if they have the same symptoms that you have. It may harm them. You can ask your health care provider or pharmacist for information about TAFINLAR and MEKINIST that is written for health care professionals. These are not all of the possible side effects of TAFINLAR and MEKINIST. For more information, talk with your health care provider or pharmacist or call The FDA-approved product labeling or prescribing information can be found at You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call FDA-1088.

8 14 15 Getting started on TAFINLAR + MEKINIST Recommended dose: TAFINLAR (dabrafenib) 150 mg twice daily + MEKINIST (trametinib) 2 mg once daily by mouth Storing TAFINLAR and MEKINIST Storing TAFINLAR Store TAFINLAR at room temperature, between 68 F and 77 F Storing MEKINIST 1st Dose Morning TAFINLAR 150 mg (2 x 75 mg) 12-HOUR INTERVAL BETWEEN TAFINLAR DOSES 2nd Dose Evening TAFINLAR 150 mg (2 x 75 mg) Once Daily MEKINIST 2 mg Take MEKINIST at the same time each day with either the morning dose or evening dose of TAFINLAR Store MEKINIST in the refrigerator between 36 F and 46 F. Do not freeze Keep MEKINIST dry and away from moisture and light The bottle of MEKINIST contains a packet that helps keep your medicine dry. Do not throw away this packet Keep MEKINIST in its original bottle. Do not place tablets in a pill box Safely throw away MEKINIST that is expired or no longer needed Take your medication on an empty stomach at least 1 hour before or at least 2 hours after eating. Keep TAFINLAR, MEKINIST, and all medicines out of the reach of children. Important dosing information Do not open, crush, or break TAFINLAR capsules If you miss a dose of TAFINLAR or MEKINIST, take it as soon as you remember, unless: You ve missed TAFINLAR and it is within 6 hours of your next scheduled dose, or You ve missed MEKINIST and it is within 12 hours of your next scheduled dose In either case, just take your next dose at the regular time. Do not make up for the missed dose. It is important that you understand and follow your doctor s directions for taking TAFINLAR + MEKINIST. Do not change your dose, or stop TAFINLAR or MEKINIST, unless your doctor tells you to. Develop a routine for taking your medicine that fits your daily schedule For example, you can take TAFINLAR + MEKINIST in the morning at 8 am, 1 hour before breakfast and then you can take TAFINLAR again in the evening at 8 pm, at least 2 hours after dinner Fever. Fever is common during treatment with TAFINLAR and MEKINIST, but it may also be serious. When taking TAFINLAR and MEKINIST, in combination, fever may happen often or may be severe. In some cases, chills or shaking chills, too much fluid loss (dehydration), low blood pressure, dizziness, or kidney problems may happen with the fever. Call your health care provider right away if you get a fever while taking TAFINLAR or MEKINIST. Skin reactions. Rash and other skin reactions are a common side effect of TAFINLAR and MEKINIST in combination. In some cases these rashes and other skin reactions can be severe, and may need to be treated in a hospital. Call your health care provider if you get any of the following symptoms: skin rash that bothers you or does not go away acne redness, swelling, peeling, or tenderness of hands or feet skin redness Increased blood sugar (hyperglycemia). Some people may develop high blood sugar or worsening diabetes during treatment with TAFINLAR and MEKINIST in combination. If you are diabetic, your health care provider should check your blood sugar levels closely during treatment with TAFINLAR and MEKINIST. Your diabetes medicine may need to be changed. Tell your health care provider if you have any of the following symptoms of severe high blood sugar: increased thirst urinating more often than normal, or urinating an increased amount of urine

9 16 17 Getting the most out of your treatment It is important to keep an open dialogue with your doctor. This will help you have more productive conversations so that, together, you can get the most out of your TAFINLAR (dabrafenib) + MEKINIST (trametinib) combination therapy. BEFORE STARTING TREATMENT Tell your health care provider about all the medications you take, and if you: Have had bleeding problems or blood clots Have heart problems Have eye problems Have lung or breathing problems Have high blood pressure (hypertension) Have liver or kidney problems Have diabetes Plan to have surgery, dental, or other medical procedures Have a deficiency of the glucose-6-phosphate dehydrogenase enzyme Have any other medical conditions Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Questions to ask your doctor Talking openly with the doctor is important in making informed decisions about your treatment journey. These suggested questions are a starting point to help you learn more about your cancer care and treatment. You are also encouraged to ask additional questions that are important to you. How will we know if the treatment is working? Is there anything I can do to help manage side effects? What symptoms or side effects should I tell you about right away? Do I need to change what I eat during treatment? Are there any limits on what I can do? What kind of exercise should I do, and how often? Will I need special tests such as imaging scans and blood tests, and how often? TAFINLAR may cause healthy red blood cells to break down too early in people with glucose-6-phosphate dehydrogenase (G6PD) deficiency. This may lead to a type of anemia called hemolytic anemia, where the body does not have enough healthy red blood cells. Tell your health care provider if you have any of the following signs or symptoms: yellow skin (jaundice) weakness or dizziness shortness of breath TAFINLAR and MEKINIST, in combination, can harm your unborn baby. Females who are able to become pregnant should use birth control (contraception) during treatment with TAFINLAR and MEKINIST in combination, and for 4 months after stopping treatment with TAFINLAR and MEKINIST.

10 18 19 Tips your doctor may suggest for coping with fever Fever is a common side effect of TAFINLAR (dabrafenib) + MEKINIST (trametinib) combination therapy. When taking TAFINLAR + MEKINIST, fever may occur frequently or may be severe. In some cases, chills or shaking chills, too much fluid loss (called dehydration ), low blood pressure, dizziness, or kidney problems can occur with the fever. What to do if you think you may have a fever As soon as you start feeling unusually warm or cold, check your temperature. Call your health care provider right away if you get a fever while taking TAFINLAR + MEKINIST. Your health care provider may recommend that you: Tips your doctor may suggest for managing other common side effects As with many medications, you may experience some side effects while taking TAFINLAR + MEKINIST. Below are some common side effects of TAFINLAR + MEKINIST treatment and tips your doctor may suggest to help you manage them. Talk to your health care provider right away if you experience any side effects. Your doctor may choose to modify, interrupt, or discontinue your dosage. Drink liquids (for example, water, soups, ice pops). Place a cold cloth on your forehead if you feel hot. RASH Your health care provider may give you a range of recommendations, from limiting exposure to the sun to using a gentle, thick, alcohol-free emollient cream to soothe affected areas. In some cases these rashes and other skin reactions can be severe, and may need to be treated in a hospital. JOINT ACHES Your health care provider may suggest over-the-counter nonsteroidal anti-inflammatory drugs to help relieve pain and swelling, along with icing and resting the affected area. Get plenty of rest. Use over-the-counter antifever medicines such as acetaminophen or ibuprofen. HEADACHE Your health care provider may suggest over-the-counter pain relievers such as acetaminophen or ibuprofen, along with lifestyle modifications including dietary, sleep, and stress reduction. DIARRHEA Your health care provider may recommend a specific diet plan along with an increase in fluids and a decrease in greasy foods, spicy foods, or foods containing dairy. Birth control using hormones (such as birth control pills, injections, or patches) may not work as well while you are taking TAFINLAR and MEKINIST in combination. You should use another effective method of birth control while taking TAFINLAR and MEKINIST in combination. Talk to your health care provider about birth control methods that may be right for you during this time. Tell your health care provider right away if you become pregnant, or think you might be pregnant, during treatment with TAFINLAR and MEKINIST in combination. and the Summary of Important Information on pages Additional common side effects: Other common side effects include cough, nausea, chills, vomiting, high blood pressure (hypertension), and swelling of the face, arms, or legs If you experience side effects, your doctor may decide to adjust your dose or stop TAFINLAR and/or MEKINIST. Do not change your dose or stop TAFINLAR or MEKINIST unless your doctor tells you to. Common side effects of TAFINLAR and MEKINIST when used in combination include: nausea chills diarrhea vomiting high blood pressure (hypertension) Keep track of your side effects, and inform your doctor about any side effect that bothers you or that does not go away. swelling of the face, arms, or legs headache joint aches cough

11 20 21 Frequently asked questions How can I learn more about melanoma? Q HOW LONG DO I TAKE TAFINLAR (dabrafenib) + MEKINIST (trametinib)? A Keep taking TAFINLAR + MEKINIST for as long as your doctor tells you. Many organizations offer support and information for people with cancer. Some of the websites listed here provide information about health insurance issues, treatment options, and support programs available for people with advanced melanoma. Several of the websites offer forums where you can connect with other patients and caregivers. National Cancer Institute Melanoma International Foundation Q WHAT IF I MISS A DOSE? A If you miss a dose of TAFINLAR or MEKINIST, take it as soon as you remember. But if you miss TAFINLAR, and it is within 6 hours of your next scheduled dose, or if you miss MEKINIST, and it is within 12 hours of your next scheduled dose, just take your next dose at the regular time. Do not make up for the missed dose. Q WHAT CAN I DO ABOUT SIDE EFFECTS? A Your doctor may change, temporarily interrupt, or stop your dose of TAFINLAR and/or MEKINIST during your treatment to help manage side effects. If you have any questions about your treatment, talk to your doctor. Melanoma Research Foundation (MRF) AIM at Melanoma National Comprehensive Cancer Network (NCCN) Guidelines for Patients with Melanoma melanoma/index.html American Academy of Dermatology Skin Cancer Foundation The organizations and websites listed above are external to Novartis. Novartis does not have control over the information provided on these websites and, therefore, cannot guarantee their accuracy and completeness. Any information you receive from these sites should not replace the medical advice from your health care provider. Q A It is important to take TAFINLAR + MEKINIST exactly as your doctor tells you. Do not change your dose or stop taking TAFINLAR or MEKINIST unless your doctor tells you. New or worsening high blood pressure (hypertension). Your health care provider should check your blood pressure during treatment with MEKINIST. Call your health care provider right away if you develop high blood pressure, your blood pressure worsens or you have severe headache, lightheadedness, or dizziness. Fertility problems. TAFINLAR and MEKINIST, in combination, may cause fertility problems in females. This could affect your ability to become pregnant. Talk to your health care provider if this is a concern for you. Low sperm counts. TAFINLAR may cause lower sperm counts in males. This could affect the ability to father a child. Talk to your health care provider if this is a concern for you. DO I NEED TO TAKE EVERY DOSE?

12 22 23 Resources and support At Novartis Pharmaceuticals Corporation, we are committed to supporting you with your treatment with TAFINLAR (dabrafenib) and MEKINIST (trametinib). That is why we developed several assistance programs to help you access the medicine you need. Co-pay Assistance Program ELIGIBLE PATIENTS PAY A $10 CO-PAY FOR THEIR TAFINLAR AND MEKINIST PRESCRIPTIONS* Pay a $10 co-pay for a 30-day supply of TAFINLAR or MEKINIST Minimum 14-day supply Maximum 90-day supply Save up to the maximum of $15,000 per calendar year on each product Save an unlimited number of times through December 31, 2017 * Limitations apply. This offer is not valid under Medicare, Medicaid, or any other federal or state program, or for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, go to Patient Assistance Now Oncology Novartis Oncology is committed to helping patients who are living with cancer receive the medicines they need. Patient Assistance Now Oncology (PANO) offers quick and easy access to information about our wide range of resources. You can get information about our PANO support programs in 2 ways: Call to speak with a member of our knowledgeable staff dedicated to making access to therapy as simple and convenient as possible; or Visit our website at: Free 30-day trial Eligible patients can receive a one-time, per-dose, free 30-day supply of TAFINLAR and MEKINIST for a US Food and Drug Administration approved indication. Your supply will be shipped directly to you so you can get started with treatment immediately. Ask your doctor or nurse about the TAFINLAR and MEKINIST 30-day free-trial program.

13 FOR PATIENTS WITH A CERTAIN TYPE OF BRAF+ ADVANCED MELANOMA BRAF Because you are BRAF+, there is a treatment option made specifically for your type of cancer. Nursing mothers. It is not known if TAFINLAR (dabrafenib) and/or MEKINIST (trametinib) pass into your breast milk. Do not breastfeed during treatment, and for 4 months after your last dose of TAFINLAR and MEKINIST. Talk to your health care provider about the best way to feed your baby during this time. These are not all of the possible side effects of TAFINLAR and MEKINIST. For more information about side effects, ask your health care provider or pharmacist. Before you take TAFINLAR and MEKINIST in combination, tell your health care provider if you: have had bleeding problems or blood clots have inflammation of the colon have heart problems have eye problems have lung or breathing problems have high blood pressure (hypertension) have liver or kidney problems have diabetes plan to have surgery, dental, or other medical procedures have a deficiency of the G6PD enzyme have any other medical conditions are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed and the Summary of Important Information on pages Novartis Pharmaceuticals Corporation East Hanover, New Jersey Novartis 3/17 MAF

A TREATMENT GUIDE FOR YOU

A TREATMENT GUIDE FOR YOU FOR PATIENTS AND CAREGIVERS A TREATMENT GUIDE FOR YOU What is BRAFTOVI + MEKTOVI? BRAFTOVI and MEKTOVI are prescription medicines used together to treat people with a type of skin cancer called melanoma:

More information

Dabrafenib (Tafinlar )

Dabrafenib (Tafinlar ) Dabrafenib (Tafinlar ) ( da-braf-e-nib ) How drug is given: By mouth Purpose: To stop the growth of cancer cells in melanoma and other cancers. How to take this drug Take this medication on an empty stomach

More information

A GUIDE TO TREATMENT WHILE TAKING RYDAPT FOR ADVANCED SM

A GUIDE TO TREATMENT WHILE TAKING RYDAPT FOR ADVANCED SM For patients with 3 types of systemic mastocytosis (SM)* * Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL) are

More information

YOUR CABOMETYX HANDBOOK

YOUR CABOMETYX HANDBOOK YOUR CABOMETYX HANDBOOK AN OVERVIEW FOR PATIENTS AND CAREGIVERS in the full Prescribing Information. Table of Contents What s included in this handbook... 3 A kidney cancer overview...4 About CABOMETYX...4

More information

Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level

Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level If you have multiple myeloma and have already tried at least 2 other types of treatment Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level What is

More information

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions Nivolumab Other Names: Opdivo About this Drug Nivolumab is used to treat cancer. It is given in the vein (IV). Possible Side Effects (More Common) Bone marrow depression. This is a decrease in the number

More information

Getting started with PROMACTA (eltrombopag)

Getting started with PROMACTA (eltrombopag) Getting started with PROMACTA (eltrombopag) Indications PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to chronic immune (idiopathic)

More information

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Dexamethasone Other Names: Decadron About This Drug Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Possible Side Effects (More Common) Increased

More information

Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer

Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer LENVIMA is a prescription medicine that is used by itself as the first treatment for a type of liver cancer called

More information

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions Capecitabine Other Names: Xeloda About This Drug Capecitabine is used to treat cancer. It is given orally (by mouth). Possible Side Effects Tired and weakness Loose bowel movements (diarrhea) Nausea and

More information

DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT

DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT LET US HELP YOU FIND A CLEARER PATH FORWARD. DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT PERSONALIZED SUPPORT FREE MEDICATION* $0 CO-PAY* WELCOME KIT RECYCLABLE

More information

TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT.

TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT. Keeping it Real. TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT. Guiding you through your treatment Taking KISQALI (ribociclib) as prescribed is essential to getting the most out of your treatment. That

More information

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib SM = Skin and Melanoma AV = AdVanced TRA = Trametinib ABOUT THIS MEDICATION

More information

Treatment Journal. Therapy Tracker TREATMENT JOURNAL

Treatment Journal. Therapy Tracker TREATMENT JOURNAL TREATMENT JOURNAL Treatment Journal & Therapy Tracker Please see full Prescribing Information, including Boxed WARNING and Medication Guide, for FARYDAK (panobinostat) capsules. This journal can help you:

More information

For the Patient: Vemurafenib Other names: ZELBORAF

For the Patient: Vemurafenib Other names: ZELBORAF For the Patient: Vemurafenib Other names: ZELBORAF Vemurafenib (vem ue raf e nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. Tell your doctor if you have

More information

Inlyta (axitinib) for Kidney Cancer

Inlyta (axitinib) for Kidney Cancer Inlyta (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg taken twice a day How

More information

Everolimus (Afinitor )

Everolimus (Afinitor ) Everolimus (Afinitor ) ( e-ver-oh-li-mus ) How drug is given: By mouth Purpose: to slow the growth of cancer cells in kidney cancer and other cancers How to take the drug Take with or without food and

More information

Take on IPF progression with OFEV

Take on IPF progression with OFEV Every breath matters Take on IPF progression with OFEV Learn more at www.ofev.com IPF=idiopathic pulmonary fibrosis. Please see throughout Understand how IPF affects you Idiopathic pulmonary fibrosis (IPF)

More information

Trastuzumab (Herceptin )

Trastuzumab (Herceptin ) Trastuzumab (Herceptin ) About This Drug Trastuzumab is used to treat cancer. It is given in the vein (IV) Possible Side Effects Bone marrow depression. This is a decrease in the number of white blood

More information

Eltrombopag (Promacta )

Eltrombopag (Promacta ) Eltrombopag (Promacta ) ( el TROM boe pag ) How drug is given: By mouth Purpose: to treat aplastic anemia and increase low platelet counts in some conditions How to take this drug 1. Take this medication

More information

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib SM = Skin and Melanoma AV = Advanced VC = Vemurafenib

More information

Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects

Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects If you have been prescribed OFEV (nintedanib) capsules for the treatment of idiopathic pulmonary fibrosis (IPF) this brochure can help you

More information

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER. For estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer. AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

More information

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions Sunitinib Other Names: Sutent About This Drug Sunitnib is used to treat cancer. It is given orally (by mouth). Possible Side Effects Headache Tiredness and weakness Soreness of the mouth and throat. You

More information

THE REAL DEAL ABOUT GETTING STARTED

THE REAL DEAL ABOUT GETTING STARTED THE REAL DEAL ABOUT GETTING STARTED Please see Important Safety Information throughout, and the Summary of Important Information on pages 44 47. Keeping it. INDICATIONS (ribociclib) is a prescription medicine

More information

What You Need to Know About ARZERRA (ofatumumab)

What You Need to Know About ARZERRA (ofatumumab) Starting your treatment for chronic lymphocytic leukemia (CLL) What You Need to Know About ARZERRA (ofatumumab) Approved Use ARZERRA is a prescription medication used: With a chemotherapy drug called chlorambucil

More information

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet For many adults with type 2 diabetes Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet Individual results may vary. Not actual patient. KAZANO is a prescription medicine

More information

THE REAL DEAL ABOUT GETTING STARTED

THE REAL DEAL ABOUT GETTING STARTED THE REAL DEAL ABOUT GETTING STARTED Please see Important Safety Information throughout, and the Summary of Important Information on pages 34 37. Keeping it real. INDICATION (ribociclib) is a prescription

More information

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods. PATIENT INFORMATION INLYTA (in-ly-ta) (axitinib) tablets Read this Patient Information before you start taking INLYTA and each time you get a refill. There may be new information. This information does

More information

Learning More Can Make a Difference

Learning More Can Make a Difference When your advanced or metastatic HER2+ breast cancer progresses on an anthracycline, a taxane, and Herceptin (trastuzumab) T U R N T O T Y K E R B + C A P E C I T A B I N E Learning More Can Make a Difference

More information

Medication Tracker for ZYTIGA (abiraterone acetate)

Medication Tracker for ZYTIGA (abiraterone acetate) Medication Tracker for YTIGA (abiraterone acetate) See the next page to help set up a medication schedule that works for you, as directed by your doctor. Write in the administration times that suit you

More information

Dabrafenib (Tafinlar )

Dabrafenib (Tafinlar ) Dabrafenib (Tafinlar ) Dabrafenib (Tafinlar ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary. This treatment aims to control the cancer and its symptoms.

More information

A GUIDE TO STARTING TREATMENT

A GUIDE TO STARTING TREATMENT A GUIDE TO STARTING TREATMENT Please see accompanying and Medication Guide. full Prescribing IDHIFA (enasidenib) is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an

More information

Discussion guide. Questions to bring to your next doctor s appointment. Notes

Discussion guide. Questions to bring to your next doctor s appointment. Notes Discussion guide Questions to bring to your next doctor s appointment As someone who has had a heart attack or has peripheral arterial disease (PAD), it s important to lower your chance of having a heart

More information

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions Methotrexate About This Drug Methotrexate is used to treat cancer. This drug is given in the vein (IV). Possible Side Effects Soreness of the mouth and throat. You may have red areas, white patches, or

More information

For the Patient: USMAVFIPI

For the Patient: USMAVFIPI For the Patient: USMAVFIPI Other Names: First-Line Treatment of Unresectable or Metastatic Melanoma Using Ipilimumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced F =

More information

Sorafenib (Nexavar ) ( sor-af-e-nib )

Sorafenib (Nexavar ) ( sor-af-e-nib ) Sorafenib (Nexavar ) ( sor-af-e-nib ) How the drug is given: by mouth Purpose: To stop the growth of cancer cells in kidney cancer, liver cancer, and other cancers How to take the drug by mouth Take on

More information

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Cobimetinib tablets Other names: COTELLIC For the Patient: Cobimetinib tablets Other names: COTELLIC Cobimetinib (koe" bi me' ti nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. The tablet contains

More information

LIVING PROOF. 23% Reduction in the risk of death compared with standardof-care. A guide to combination treatment with RYDAPT

LIVING PROOF. 23% Reduction in the risk of death compared with standardof-care. A guide to combination treatment with RYDAPT My LIVING PROOF THAT TREATING NEWLY DIAGNOSED FLT3-POSITIVE AML HAS CHANGED 23% Reduction in the risk of death compared with standardof-care chemotherapy alone A specific median overall survival (the time

More information

One daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection.

One daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection. TRUVADA for PrEP is a prescription medicine that can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices. TRUVADA for PrEP is only for people

More information

Medication Guide Enbrel (en-brel) (etanercept)

Medication Guide Enbrel (en-brel) (etanercept) Medication Guide Enbrel (en-brel) (etanercept) Read the Medication Guide that comes with Enbrel before you start using it and each time you get a refill. There may be new information. This Medication Guide

More information

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Bendamustine Other names: TREANDA For the Patient: Bendamustine Other names: TREANDA Bendamustine (ben'' da mus' teen) is a drug that is used to treat some types of cancer (lymphoma). It is a clear liquid that is injected into a vein.

More information

Dabrafenib and Trametinib

Dabrafenib and Trametinib Dabrafenib and Trametinib Dabrafenib and Trametinib This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary. This treatment aims to control the cancer and its

More information

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor TECENTRIQ DISCUSSION SUPPORT What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: A type of bladder

More information

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Ponatinib Other names: ICLUSIG For the Patient: Other names: ICLUSIG (poe na' ti nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. The tablet contains lactose. Tell your doctor if you

More information

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib? 1 of 5 6/10/2016 3:46 PM Generic Name: bortezomib (bor TEZ oh mib) Brand Name: Velcade What is bortezomib? Bortezomib interferes with the growth of some cancer cells and keeps them from spreading in your

More information

REDUCE THE HURT REDUCE THE HARM

REDUCE THE HURT REDUCE THE HARM IF YOU HAVE OSTEOARTHRITIS (OA) OR RHEUMATOID ARTHRITIS (RA) REDUCE THE HURT AND REDUCE THE HARM DUEXIS reduces the risk of developing stomach ulcers for patients who are taking ibuprofen for OA/RA INDICATIONS

More information

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers Medication Information Sheet (pack li TAX ell) This document provides general information about your medication. It does not replace the advice of your health care professional. Always discuss your therapy

More information

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE HELP GET READY FOR YOUR UPCOMING PROCEDURE READY. SET. DOPTELET. Full Prescribing Information for DOPTELET (avatrombopag), including Patient For adults with chronic liver disease and a low platelet count

More information

For the Patient: USMAVNIV

For the Patient: USMAVNIV For the Patient: USMAVNIV Other Names: Treatment of Unresectable or Metastatic Melanoma Using Nivolumab U = Undesignated (requires special approval) SM = Skin and Melanoma AV = AdVanced NIV = NIVolumab

More information

For the Patient: Olaparib tablets Other names: LYNPARZA

For the Patient: Olaparib tablets Other names: LYNPARZA For the Patient: Olaparib tablets Other names: LYNPARZA Olaparib (oh lap' a rib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. Tell your doctor if you have

More information

GLEEVEC PATIENT RESOURCES

GLEEVEC PATIENT RESOURCES GLEEVEC TALKING WITH YOUR DOCTOR ABOUT KIT+ GIST AND ITS TREATMENT When you have KIT-positive gastrointestinal stromal tumor (KIT+ GIST), you will likely have many questions and may, at times, feel overwhelmed

More information

What are my treatment support resources?

What are my treatment support resources? What are my treatment support resources? Get help when you need it. Click here for full Prescribing Information including risk of SERIOUS SIDE EFFECTS and Medication Guide. We re here to help you......

More information

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help Understanding your risk of blood clots from hospital to home and how Bevyxxa may help People who take Bevyxxa and have medicine injected into their spinal and epidural area, or have a spinal puncture,

More information

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you: MEDICATION GUIDE Lamotrigine (lam-oh-try-jeen) Tablets USP Rx only What is the most important information I should know about lamotrigine tablets? 1. Lamotrigine tablets may cause a serious skin rash that

More information

A medicine to block the amount of acid produced in the stomach (H2 blocker): about 10 hours before about 2 hours after

A medicine to block the amount of acid produced in the stomach (H2 blocker): about 10 hours before about 2 hours after TRACKING JOURNAL YOUR TRACKING JOURNAL Throughout your treatment with TASIGNA (nilotinib), your doctor will prescribe regular tests to see if your treatment is working. It s important to keep up with your

More information

For the Patient: USMAVPEM

For the Patient: USMAVPEM For the Patient: USMAVPEM Other Names: Treatment of Unresectable or Metastatic Melanoma Using Pembrolizumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced PEM = Pembrolizumab

More information

How does my new treatment work?

How does my new treatment work? How does my new treatment work? Get to know KEVZARA better. Click here for full Prescribing Information including 1 risk of SERIOUS SIDE EFFECTS and Medication Guide. You're starting KEVZARA... GOT A QUESTION?

More information

PATIENT GUIDE. Highlights of Important Safety Information Warnings and Precautions. Your guide to treatment with Signifor LAR for acromegaly

PATIENT GUIDE. Highlights of Important Safety Information Warnings and Precautions. Your guide to treatment with Signifor LAR for acromegaly PATIENT GUIDE Your guide to treatment with Signifor LAR for acromegaly Signifor LAR is indicated for the treatment of patients with acromegaly for whom surgery has not worked well enough or who cannot

More information

Imatinib (Gleevec ) ( eye-mat-eh-nib )

Imatinib (Gleevec ) ( eye-mat-eh-nib ) Imatinib (Gleevec ) ( eye-mat-eh-nib ) How drug is given: by mouth Purpose: stops growth of cancer cells in leukemia, gastrointestinal stromal tumors (GIST), and other cancers How to take the drug by mouth

More information

For the Patient: ULUAVPMTN

For the Patient: ULUAVPMTN ABOUT THIS MEDICATION For the Patient: ULUAVPMTN Other Names: Maintenance Therapy of Advanced n-small Cell Lung Cancer (NSCLC) with Pemetrexed U = Undesignated (requires special approval) LU = LUng AV

More information

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP) MEDICATION GUIDE Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP) Read this Medication Guide before you start taking PEGANONE and each time you get a refill. There may be new information.

More information

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab GI = GastroIntestinal AV = Advanced PANI = Panitumumab ABOUT THIS MEDIATION

More information

(sunitinib malate) for Kidney Cancer

(sunitinib malate) for Kidney Cancer Sutent (sunitinib malate) for Kidney Cancer Sutent is a medication used to treat adult patients with kidney cancer that has been surgically removed and at high risk of recurrence, or advanced kidney cancer

More information

IMBRUVICA (ibrutinib) Your ally to help fight previously treated MCL

IMBRUVICA (ibrutinib) Your ally to help fight previously treated MCL IMBRUVICA (ibrutinib) Your ally to help fight previously treated MCL An oral therapy you take once a day, on your own, at a time and place convenient for you What is IMBRUVICA? IMBRUVICA is a prescription

More information

HOW TO USE. 75 mg capsules. and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment

HOW TO USE. 75 mg capsules. and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment HOW TO USE 75 mg capsules and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment TARGRETIN capsules should not be used by women who are pregnant, believe they may be pregnant, or are

More information

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. For the Patient: Other names: TASIGNA (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Blood tests may be taken regularly during treatment.

More information

Midostaurin (Rydapt )

Midostaurin (Rydapt ) Midostaurin (Rydapt ) ( mye doe STAW rin ) How drug is given: By mouth Purpose: To stop the growth of cancer cells in acute myeloid leukemia (AML) and other cancers. How to take this drug 1. Take this

More information

Docetaxel (Taxotere )

Docetaxel (Taxotere ) Page 1 of 5 Docetaxel (Taxotere ) About This Drug Docetaxel is used to treat cancer. It is given in the vein (IV). Possible Side Effects Bone marrow depression. This is a decrease in the number of white

More information

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: LUAVPG (Carboplatin Option) For the Patient: LUAVPG (Carboplatin Option) Other Names: Treatment of Advanced n-small Cell Lung Cancer with Carboplatin and Gemcitabine LU = LUng AV = AdVanced PG = CarboPlatin, Gemcitabine ABOUT THIS

More information

HAS TSC BEYOND YOUR TSC-RELATED KIDNEY TUMORS, THERE S YOU. AND GRANDMA'S SECRET RECIPE

HAS TSC BEYOND YOUR TSC-RELATED KIDNEY TUMORS, THERE S YOU. AND GRANDMA'S SECRET RECIPE HAS TSC Not an actual patient. AND GRANDMA'S SECRET RECIPE TSC, tuberous sclerosis complex. BEYOND YOUR TSC-RELATED KIDNEY TUMORS, THERE S YOU. Learn more at www.afinitor.com/angiomyolipoma INDICATION

More information

For the Patient: LUAVPEM

For the Patient: LUAVPEM For the Patient: LUAVPEM Other Names: Second-Line Treatment Of Advanced Non- Small Cell Lung Cancer (NSCLC) With Pemetrexed LU = LUng AV = AdVanced PEM = PEMetrexed ABOUT THIS MEDICATION What is this drug

More information

Lenvatinib (Lenvima ) ( len-va-ti-nib )

Lenvatinib (Lenvima ) ( len-va-ti-nib ) Lenvatinib (Lenvima ) ( len-va-ti-nib ) How drug is given: By mouth Purpose: To treat thyroid cancer or other cancers How to take this drug This medicine can be taken with or without food. Take each dose

More information

MEDICATION GUIDE XIGDUO XR (ZIG- DO- OH X- R) (dapagliflozin and metformin HCL extended-release) Tablets

MEDICATION GUIDE XIGDUO XR (ZIG- DO- OH X- R) (dapagliflozin and metformin HCL extended-release) Tablets XIGDUO XR (dapagliflozin and metformin HCl extended-release) tablets 5 MEDICATION GUIDE XIGDUO XR (ZIG- DO- OH X- R) (dapagliflozin and metformin HCL extended-release) Tablets What is the most important

More information

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: Trastuzumab emtansine Other names: KADCYLA For the Patient: Trastuzumab emtansine Other names: KADCYLA Trastuzumab emtansine (tras tooz' ue mab em tan' seen) is a drug that is used to treat some types of cancer. Trastuzumab emtansine is a clear

More information

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: LUAVPP (Carboplatin Option) ABOUT THIS MEDICATION For the Patient: LUAVPP (Carboplatin Option) Other Names: Treatment of Advanced n-small Cell Lung Cancer with Carboplatin and Pemetrexed LU = LUng AV = AdVanced PP = CarboPlatin,

More information

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Read this Patient Information before you start taking VERSACLOZ and each time you get a refill. There may be new information. This

More information

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. For the Patient: Other names: Sorafenib NEXAVAR Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. A blood test may be taken before each

More information

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: Fludarabine injection Other names: FLUDARA For the Patient: Fludarabine injection Other names: FLUDARA Fludarabine (floo-dare-a-been) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein. Tell

More information

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Eribulin Other names: HALAVEN For the Patient: Eribulin Other names: HALAVEN Eribulin (er'' i bue' lin) is a drug that is used to treat some types of cancer. It is a clear liquid that is injected into a vein. Tell your doctor if you

More information

WE RE IN A CONSTANT STRUGGLE. BUT WITH AFINITOR, WE VE FOUND ANOTHER OPTION.

WE RE IN A CONSTANT STRUGGLE. BUT WITH AFINITOR, WE VE FOUND ANOTHER OPTION. SEGA TSC Novartis Pharmaceuticals Corporation is committed to supporting individuals affected by SEGA with TSC through therapeutic innovation, patient assistance, and support of advocacy organizations.

More information

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct. For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct. GI = GastroIntestinal P = Pancreas GEM = Gemcitabine ABOUT THIS MEDIATION What is this drug used for? Gemcitabine

More information

For the Patient: ULUAVPMB

For the Patient: ULUAVPMB For the Patient: ULUAVPMB Other Names: Treatment of Advanced Non-Small Cell Lung Cancer Using Pembrolizumab U = Undesignated (requires special approval) LU = LUng AV = AdVanced PMB = PeMBrolizumab ABOUT

More information

Page 1 of 5 VERZENIO abemaciclib tablet Eli Lilly and Company AddendaIndex Summary View All Sections HIGHLIGHTS OF PRESCRIBING INFORMATION FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE

More information

PATIENT INFORMATION. Metformin Hydrochloride Extended-Release Tablets USP (met-for-min HYE-droe-KLOR-ide)

PATIENT INFORMATION. Metformin Hydrochloride Extended-Release Tablets USP (met-for-min HYE-droe-KLOR-ide) PATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets USP (met-for-min HYE-droe-KLOR-ide) What is the most important information I should know about metformin hydrochloride extended-release

More information

Regorafenib (Stivarga )

Regorafenib (Stivarga ) Page 1 of 5 Regorafenib (Stivarga ) About This Drug Regorafenib is used to treat cancer. It is given orally (by mouth). Possible Side Effects Bone marrow depression. This is a decrease in the number of

More information

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away from children. If a child accidentally takes ZUBSOLV, this is a

More information

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules Read this Medication Guide before you start taking Valproic Acid Capsules and each time you get a refill. There may be new information. This information

More information

FDA APPROVED MEDICATION GUIDE

FDA APPROVED MEDICATION GUIDE FDA APPROVED MEDICATION GUIDE Valproic Acid Oral Solution Read this Medication Guide before you start taking valproic acid and each time you get a refill. There may be new information. This information

More information

What are some things I need to know or do while I take

What are some things I need to know or do while I take PATIENT & CAREGIVER EDUCATION Cyclophosphamide Brand Names: Canada Procytox What is this drug used for? It is used to treat cancer. It is used to treat nephrotic syndrome. It may be g iven to you for other

More information

If you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA

If you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA If you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA IMPORTANT SAFETY INFORMATION WARNING: HYPONATREMIA See full prescribing information for complete boxed warning. NOCTIVA

More information

GLEEVEC (imatinib mesylate) PATIENT RESOURCES

GLEEVEC (imatinib mesylate) PATIENT RESOURCES Talking with your doctor about Ph+ CML and its treatment When you have Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), it s important to take an active role in your care. You will

More information

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS HCP Prescribing Information Date/Version January 2015 Version 2 Page: 1 of 5 I. ALL CLAIMS: HEALTH CARE PROFESSIONALS Indications and Usage Saxenda (liraglutide [rdna origin] injection) is indicated as

More information

EMBRACING TODAY TOGETHER. A Guide For Caregivers

EMBRACING TODAY TOGETHER. A Guide For Caregivers EMBRACING TODAY TOGETHER A Guide For Caregivers IBRANCE is a prescription medicine that is used along with the medicine letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive,

More information

MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP)

MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP) MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP) Read this Medication Guide before you start taking JANTOVEN (Warfarin Sodium Tablets, USP) and each time you get a refill.

More information

PATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets (met-for-min HYE-droe-KLOR-ide) Rx only

PATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets (met-for-min HYE-droe-KLOR-ide) Rx only PATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets (met-for-min HYE-droe-KLOR-ide) Rx only What is the most important information I should know about metformin hydrochloride extended-release

More information

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Everolimus tablets Other names: AFINITOR For the Patient: Everolimus tablets Other names: AFINITOR Everolimus (e'' ver oh' li mus) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. Tell your doctor if

More information

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider Have a healthy discussion Use this guide to start a conversation with your healthcare provider MAKE THE CONVERSATION COUNT Here are some things you may want to reflect on and discuss with your healthcare

More information